Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kirschfink

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Immunobiology|October 25, 2002
C1-inhibitor and transplantationMichael Kirschfink
Frontiers in Immunology|April 27, 2019
Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for InterventionZvi Fishelson, Michael Kirschfink
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Modern complement analysisMichael Kirschfink, Tom E Mollnes
Molecular Immunology|July 14, 2005
Strategies of therapeutic complement inhibitionTom E Mollnes, Michael Kirschfink
Molecular Immunology|July 20, 2014
Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approachAnete Sevciovic Grumach, Michael Kirschfink
Advances in Experimental Medicine and Biology|August 9, 2006
Complement analysis in clinic and researchTom E Mollnes, Michael Kirschfink
Molecular Immunology|August 18, 2019
Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical managementJutta Schröder-Braunstein, Michael Kirschfink
Seminars in Thrombosis and Hemostasis|September 25, 2010
Therapeutic complement inhibition: new developmentsWoodruff Emlen, Wenhan Li, Michael Kirschfink
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 29, 2002
Mechanism of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfacesRuedger Kopp, Khosrow Mottaghy, Michael Kirschfink
Immunobiology|December 22, 2015
The complement system in cancer: Ambivalence between tumour destruction and promotionSrinivas Mamidi, Simon Höne, Michael Kirschfink
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Immunobiology|October 25, 2002
C1-inhibitor and transplantationMichael Kirschfink
Frontiers in Immunology|April 27, 2019
Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for InterventionZvi Fishelson, Michael Kirschfink
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Modern complement analysisMichael Kirschfink, Tom E Mollnes
Molecular Immunology|July 14, 2005
Strategies of therapeutic complement inhibitionTom E Mollnes, Michael Kirschfink
Molecular Immunology|July 20, 2014
Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approachAnete Sevciovic Grumach, Michael Kirschfink
Advances in Experimental Medicine and Biology|August 9, 2006
Complement analysis in clinic and researchTom E Mollnes, Michael Kirschfink
Molecular Immunology|August 18, 2019
Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical managementJutta Schröder-Braunstein, Michael Kirschfink
Seminars in Thrombosis and Hemostasis|September 25, 2010
Therapeutic complement inhibition: new developmentsWoodruff Emlen, Wenhan Li, Michael Kirschfink
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 29, 2002
Mechanism of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfacesRuedger Kopp, Khosrow Mottaghy, Michael Kirschfink
Immunobiology|December 22, 2015
The complement system in cancer: Ambivalence between tumour destruction and promotionSrinivas Mamidi, Simon Höne, Michael Kirschfink
Pageof 10